Kimberly-Clark (NASDAQ:KMB – Get Free Report) had its price target lowered by analysts at BNP Paribas Exane from $127.00 to $110.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “neutral” rating on the stock. BNP Paribas Exane’s price target suggests a potential upside of 0.73% from the stock’s current price.
Several other analysts also recently weighed in on the company. Cowen reiterated a “hold” rating on shares of Kimberly-Clark in a research report on Tuesday, November 4th. Wells Fargo & Company decreased their target price on shares of Kimberly-Clark from $129.00 to $110.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. BNP Paribas reiterated a “neutral” rating and issued a $110.00 price target on shares of Kimberly-Clark in a research note on Monday. Evercore ISI restated an “in-line” rating and set a $120.00 price objective (down previously from $150.00) on shares of Kimberly-Clark in a research report on Tuesday, November 4th. Finally, TD Cowen dropped their target price on Kimberly-Clark from $135.00 to $130.00 and set a “hold” rating for the company in a research report on Friday, October 31st. Three analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Kimberly-Clark presently has an average rating of “Hold” and an average target price of $126.00.
Get Our Latest Report on Kimberly-Clark
Kimberly-Clark Stock Performance
Kimberly-Clark (NASDAQ:KMB – Get Free Report) last posted its earnings results on Thursday, October 30th. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.45 by $0.37. Kimberly-Clark had a return on equity of 184.87% and a net margin of 12.87%.The company had revenue of $4.15 billion during the quarter, compared to the consensus estimate of $4.14 billion. During the same quarter last year, the firm earned $1.83 earnings per share. The company’s revenue was up .1% on a year-over-year basis. On average, equities analysts forecast that Kimberly-Clark will post 7.5 EPS for the current year.
Institutional Trading of Kimberly-Clark
Several hedge funds have recently bought and sold shares of KMB. Investment Research & Advisory Group Inc. bought a new stake in Kimberly-Clark during the 2nd quarter valued at about $25,000. Cloud Capital Management LLC purchased a new position in shares of Kimberly-Clark during the third quarter worth approximately $25,000. True Wealth Design LLC raised its stake in shares of Kimberly-Clark by 177.6% during the third quarter. True Wealth Design LLC now owns 211 shares of the company’s stock valued at $26,000 after acquiring an additional 135 shares in the last quarter. Princeton Global Asset Management LLC boosted its holdings in shares of Kimberly-Clark by 989.5% in the second quarter. Princeton Global Asset Management LLC now owns 207 shares of the company’s stock valued at $27,000 after purchasing an additional 188 shares during the period. Finally, Winnow Wealth LLC purchased a new stake in shares of Kimberly-Clark in the second quarter valued at approximately $27,000. Institutional investors and hedge funds own 76.29% of the company’s stock.
Kimberly-Clark Company Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Featured Articles
- Five stocks we like better than Kimberly-Clark
- CD Calculator: Certificate of Deposit Calculator
- Why Silver Beat Gold and the S&P in 2025—And What Comes Next
- What is the FTSE 100 index?
- 5 Healthcare Names to Watch as Sector Rotation Is in Full Swing
- Want to Profit on the Downtrend? Downtrends, Explained.
- NuScale’s Shocking Q3 Was a Bullish Signal in Disguise
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.
